According to Amylyx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $38.8 M. In 2022 the company made an earning of -$0.21 B a decrease over its 2021 earnings that were of -$82.72 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $38.8 M | -119.27% |
2022 | -$0.21 B | 143.41% |
2021 | -$82.72 M |